Neil Torbett, PhoreMost CEO

Seek­ing first-in-class glo­ry, Roche en­lists biotech part­ner that prides it­self on crack­ing 'un­drug­gable' tar­gets

Roche is on the hunt for some first-in-class projects — and, with the help of a new part­ner, it’s start­ing from scratch.

The phar­ma gi­ant has …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.